WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016096143) CRYSTALLINE FORM OF 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE SODIUM SALT, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND METHOD FOR THE PRODUCTION OF SAID FORM
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/096143    International Application No.:    PCT/EP2015/002555
Publication Date: 23.06.2016 International Filing Date: 18.12.2015
IPC:
C07D 237/32 (2006.01), A61K 31/502 (2006.01), A61P 37/02 (2006.01), A61P 9/10 (2006.01)
Applicants: METRIOPHARM AG [CH/CH]; Bleicherweg 45 CH-8002 Zürich (CH)
Inventors: MARTIN, Thomas; (DE).
BREU, Josef; (DE).
BRYSCH, Wolfgang; (DE).
KOSEL, David; (DE).
LUDESCHER, Beate; (DE).
NIEDERMAIER, Michael; (DE).
VON WEGERER, Jörg; (DE)
Priority Data:
14004274.8 18.12.2014 EP
Title (DE) KRISTALLINE FORM VON 5-AMINO-2,3-DIHYDROPHTHALAZIN-1,4-DION NATRIUMSALZ, DIESE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN UND VERFAHREN ZU IHRER HERSTELLUNG
(EN) CRYSTALLINE FORM OF 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE SODIUM SALT, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND METHOD FOR THE PRODUCTION OF SAID FORM
(FR) FORME CRISTALLINE DU SEL DE SODIUM DE 5-AMINO-2,3-DIHYDROPHTALAZINE-1,4-DIONE, PRÉPARATIONS PHARMACEUTIQUES LA CONTENANT ET PROCÉDÉS POUR SA PRODUCTION
Abstract: front page image
(DE)Die Erfindung betrifft die Bereitstellung einer neuen kristallinen Form zu 5-Amino-2,3- dihydrophthalazin-1,4-dion Natriumsalz, eine Verwendung dieser Form zu medizinischen Zwecken, Verfahren zur Herstellung der erfindungsgemäßen kristallinen Form, sowie diese enthaltende pharmazeutische Zubereitungen.
(EN)The invention relates to the provision of a new crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, a use of this form for medical purposes, methods for the production of the crystalline form according to the invention and to pharmaceutical preparations containing them.
(FR)L'invention concerne la préparation d'une nouvelle forme cristalline du sel de sodium de 5-amino-2,3-dihydrophtalazine-1,4-dione, une utilisation de cette forme à des fins médicales, des procédés de production de la forme cristalline selon l'invention, ainsi que des préparations pharmaceutiques la contenant.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: German (DE)
Filing Language: German (DE)